Nanostructured lipid carriers as drug delivery systems of rifapentine: a tool to overcome the drawbacks of tuberculosis oral therapy uri icon

autores

  • Alexandre C. C. Vieira
  • Luise L. Chaves
  • Marina Barroso Pereira Pinheiro
  • Mário A. Barbosa
  • Susana G. Santos
  • Reis, Salette

data de publicação

  • abril 2016